← Back to patent-cliff list
阿折地平
Tier C — Watch / tradeAzelnidipine
第一三共株式会社
Originator
2003
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Voltage-gated L-type calcium channel
Brand：Calblock
Indications (approved)：高血压
Regional status
US
-
EU
-
China
批准上市
2008-05-04
Japan
批准上市
2003-01-31
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Azelnidipine?
Approved indications include: 高血压.
When does the Azelnidipine patent expire?
No public expiry year is available for Azelnidipine yet; this page updates once verified.
How do I get a quote for Azelnidipine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25